...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: ZHCLF up 290% to $0.16...question

Do you own any RVX shares?

Are you from Canada? May I ask the name of your broker?

Would you know the number of outstanding shares for ZHCLF?

 

Koo 

Share
New Message
Please login to post a reply